ArticleJournal for immunotherapy of cancer2025

Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma.

Mohammad Jad Moussa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.